Vascular and Coagulation Disorders of the Liver

Publisher Website
Google Scholar
Abstract
The liver has three vascular systems-the portal vein, the hepatic vein, and the hepatic artery-but the hepatic artery seldom causes problems, unlike other arteries in other parts of the body. The arterial system of the body develops obliterative changes with morbidity as the age advances. Although the hepatic artery, splenic artery, and mesenteric arteries originate from the same aorta in the abdomen, the hepatic artery rarely develops insufficiency. Atherosclerotic changes in the mesenteric artery cause malperfusion that leads to abdominal angina; aneurysm of the abdominal aorta is relatively common in the aged. The hepatic artery seems to be spared of such changes. Calcification of the abdominal aorta and the splenic artery is particularly common and severe in patients with chronic renal failure because of hyperparathyroidism, but the hepatic artery seldom calcifies. The liver is vital for life, and certain ill-defined mechanisms are operative in preventing calcific and atherosclerotic changes of the hepatic artery, perhaps serving a teleologic purpose. By contrast, the venous systems of the liver are amenable to changes that cause circulatory disturbances, such as thrombosis, varices, and collateral veins. Thus, this issue of Seminars in Liver Disease deals only with venous systems of the liver. Budd-Chiari syndrome was primarily described in patients with hepatic vein thrombosis within the liver induced by infection, but subsequent reports on similar clinical symptoms by other causes obscured the distinction between primary hepatic vein thrombosis and thrombosis of the inferior vena cava (IVC) affecting orifices of hepatic veins. The clinical features of classical hepatic vein thrombosis (discussed by Valla in this issue) and primary thrombosis of the hepatic portion of the IVC affecting hepatic vein orifices (described by Okuda) are quite different; the former is clinically more severe, sometimes requiring liver transplantation. Primary IVC thrombosis, which preferentially occurs in the hepatic portion of the IVC and eventually turns into a membranous obstruction has milder onset, but recurs frequently, and slowly progresses into congestive cirrhosis, which may be complicated by hepatocellular carcinoma. In southern Africa, among the Bantus nearly half the patients with membranous IVC obstruction develop hepatocellular carcinoma, whereas this complication is extremely rare in primary hepatic vein thrombosis. A number of thrombogenic or hypercoagulable disorders are known to cause hepatic vein thrombosis, and Valla discusses them with emphasis on myeloproliferative disorders. Earlier Ludwig, and more recently Okuda, emphasized the need for separating hepatic vein thrombosis and IVC thrombosis and abandoning the term Budd Chiari syndrome; the suggested term for IVC thrombosis is obliterative hepatocavopathy. In France, etiologic or thrombogenic disorders are found in nearly all cases of primary hepatic vein thrombosis. The same does not apply to IVC thrombosis, which is frequently idiopathic with no demonstrable hypercoagulability. In Nepal, where IVC thrombosis or obliterative hepatocavopathy is endemic and is one of the most common liver diseases, patients frequently have bacterial infection or bacteremia. Such an etiology also may apply to some of the sporadic cases of obliterative hepatocavopathy elsewhere. The membranous obstruction of IVC was once thought by many to represent a congenital vascular malformation or a coarctation comparable with aortic coarctation. This disease mostly occurs in adults, and the congenital theory has recently been completely denied. The membranous obstruction is not always a membrane, and could be much thicker or thinner; it is unequivocally a sequela to IVC thrombosis. Veno-occlusive disease (VOD) is an ailment that affects central veins, the most peripheral hepatic veins. It was first described in a family in Cape Town, South Africa, who coharvested wheat and the seed of Senecio, a weed. Eating bread contaminated with Senecio produced a cirrhosis-like disease with ascites. Subsequently, a nonportal type of cirrhosis was reported among the inhabitants of Jamaica who drank herbal teas containing pyrrolizidine. A number of small outbreaks of a severe liver disease were observed in Afghan villages where toxic weed contaminated grain, and dogs also developed ascites and died. More recently, it was found that immunosuppressants, notably azathioprine, and chemotherapeutic agents also cause VOD; many VOD cases associated with kidney and liver transplantation have been documented. Histopathologically, it was primarily thought that VOD represented an obliterative disease of hepatic venules. Recent studies suggest, however, that the primary site of toxic injury is sinusoidal endothelium followed by a series of biologic processes that lead to circulatory disturbances compromising centrilobular hepatocytes and cause fibrosis and obstruction to hepatic blood flow. It was also found that hepatic venule involvement is not essential to the development of clinical symptoms. McDonald has proposed that the disease be renamed sinusoidal obstruction syndrome (SOS). In this issue, McDonald and associates describe in detail the histogenesis of SOS and clinical manifestations in patients who received high-dose myeloablative therapy in preparation for hematopoietic stem cell transplantation. Among various noncirrhotic disorders that cause portal hypertension, idiopathic portal hypertension (IPH) in Japan and noncirrhotic portal fibrosis (NCPF) in India are more common than other portal hypertensive diseases. IPH, first described by Banti as a spleen disorder toward the end of the 19th century in Italy, is the disease most extensively studied in Japan. Okudaira et al discuss the results of the study of IPH conducted in Japan by a research group...

This publication has 0 references indexed in Scilit: